carmustine has been researched along with amphotericin b in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (60.87) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 5 (21.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Alves, ÉV; Braga, SF; Coelho, EF; de Oliveira, RB; Duarte, MC; Ferreira, RS; Fradico, JR; Júnior, PA; Lage, PS; Ribeiro, TG; Romanha, AJ; Steindel, M; Tonini, ML | 1 |
| Klahr, C; Presant, CA; Santala, R | 1 |
| Dieckman, J; Lynch, R; Medoff, G; Tolen, S; Valeriote, F | 1 |
| Perez, CA; Stewart, CC; Valeriote, FA | 1 |
| Bhuyan, BK; Day, KJ; Fraser, TJ; Loughman, BE | 1 |
| Medoff, G; Ryan, J; Tolen, S; Valeriote, F | 1 |
| Gatewood, D; Klahr, C; Olander, J; Presant, CA | 1 |
| Lynch, RG; Medoff, G; Valeriote, F | 1 |
| Drewinko, B; Gottlieb, JA; Loo, TL | 1 |
| Brajtburg, J; Elberg, S; Medoff, G; Schechtman, KB | 1 |
| Brajtburg, J; Elberg, S; Kobayashi, GS; Medoff, G | 1 |
| Kobayashi, GS; Medoff, G; Schlessinger, D | 1 |
| Kobayashi, GS; Lynch, RG; Medoff, G; Schlessinger, D; Valeriote, F | 1 |
| Hahn, GM; Shiu, EC | 1 |
| Hillinger, S; Klahr, C; Presant, CA | 1 |
| Dieckman, J; Medoff, G; Valeriote, F | 1 |
| Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K | 1 |
| Glick, JA; Graham, RS; Voils, SA | 1 |
23 other study(ies) available for carmustine and amphotericin b
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis and evaluation of the antiparasitic activity of bis-(arylmethylidene) cycloalkanones.
Topics: Animals; Antiprotozoal Agents; Cell Line; Chagas Disease; Fibroblasts; Humans; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages; Mice; Models, Molecular; Trypanosoma cruzi | 2014 |
Amphotericin B induction of sensitivity to adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) plus cyclophosphamide in human neoplasia.
Topics: Adult; Aged; Amphotericin B; Breast Neoplasms; Carmustine; Cyclophosphamide; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Multiple Myeloma; Neoplasms | 1977 |
Growth and rejection of leukemia cells in individual mice after combined treatment with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Amphotericin B; Animals; Bone Marrow; Brain Neoplasms; Carmustine; Cell Division; Clone Cells; Drug Therapy, Combination; Female; Leukemia, Experimental; Mice; Mice, Inbred AKR; Time Factors | 1978 |
Preliminary observations on the effect of glucan in combination with radiation and chemotherapy in four murine tumors.
Topics: Amphotericin B; Animals; Antineoplastic Agents; Carmustine; Drug Therapy, Combination; Female; Glucans; Immunity; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Sarcoma, Experimental | 1978 |
Comparison of different methods of determining cell viability after exposure to cytotoxic compounds.
Topics: Amphotericin B; Antibiotics, Antineoplastic; Antineoplastic Agents; Carmustine; Cell Adhesion; Cell Line; Cell Survival; Chlorambucil; Cytarabine; Cytological Techniques; Doxorubicin; Mechlorethamine; Nogalamycin; Pactamycin; Tubercidin; Vincristine | 1976 |
Response of transplanted AKR leukemia to combination therapy with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea: dose and schedule dependency.
Topics: Amphotericin B; Animals; Carmustine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Immunity; Immunosuppression Therapy; Leukemia, Experimental; Leukemia, Lymphoid; Lymphocytes; Mice; Mice, Inbred AKR | 1977 |
Amphotericin B plus 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC no. 409962) in advanced cancer. Phase I and preliminary phase II results.
Topics: Amphotericin B; Blood Platelets; Bone Marrow; Carmustine; Drug Therapy, Combination; Granulocytes; Humans; Neoplasm Metastasis; Neoplasms | 1976 |
A murine model for central nervous system leukemia and its possible relevance to human leukemia.
Topics: Amphotericin B; Animals; Brain; Carmustine; Central Nervous System Diseases; Disease Models, Animal; Female; Leukemia, Experimental; Leukemia, Lymphoid; Meninges; Mice; Mice, Inbred AKR; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paralysis; Spinal Cord | 1975 |
A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells.
Topics: Amphotericin B; Carmustine; Cell Line; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Lomustine; Lymphoma; Neoplasms, Experimental; Nitrosourea Compounds; Semustine; Time Factors; Vitamin A | 1976 |
Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.
Topics: Amphotericin B; Carmustine; Cell Line; Drug Therapy, Combination; Glutathione; Humans; L-Lactate Dehydrogenase; Leukemia, Promyelocytic, Acute; Lomustine; Nitrosourea Compounds | 1990 |
Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas.
Topics: Amphotericin B; Candida albicans; Carmustine; Catalase; Cyanates; Drug Interactions; Lomustine | 1988 |
Brief communication: polyene potentiation of antitumor agents.
Topics: Amphotericin B; Animals; Carmustine; Cell Division; Cell Survival; Clone Cells; Drug Synergism; L Cells; Leukemia; Mice; Mice, Inbred AKR; RNA; Spleen | 1973 |
Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia.
Topics: Amphotericin B; Animals; Bone Marrow Cells; Brain Neoplasms; Carmustine; Cell Survival; Clone Cells; Drug Synergism; Drug Therapy, Combination; Female; Kinetics; Leukemia, Experimental; Mice; Mice, Inbred AKR; Neoplasm Metastasis; Paralysis; Spinal Cord Neoplasms; Spleen; Subarachnoid Space | 1974 |
Effect of pH and elevated temperatures on the cytotoxicity of some chemotherapeutic agents on Chinese hamster cells in vitro.
Topics: Amphotericin B; Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cell Line; Cell Survival; Cricetinae; Cricetulus; Hot Temperature; Hydrogen-Ion Concentration; Kinetics; Methotrexate | 1983 |
Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Amphotericin B; Bone Marrow; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carmustine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1980 |
Potentiation of anticancer agents by amphotericin B.
Topics: Amphotericin B; Animals; Antineoplastic Agents; Carmustine; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Drug Synergism; Female; Leukemia, Experimental; Mechlorethamine; Mice; Mice, Inbred AKR; Vincristine | 1981 |
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases, Fungal; Male; Melphalan; Neoplasm Recurrence, Local; Opportunistic Infections; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Prednisone; Procarbazine; Salvage Therapy; Skin; Transplantation, Homologous; Vinblastine; Vincristine | 2001 |
Candida meningitis post Gliadel wafer placement successfully treated with intrathecal and intravenous amphotericin B.
Topics: Amphotericin B; Antineoplastic Agents; Candidiasis; Carmustine; Decanoic Acids; Drug Implants; Female; Humans; Injections, Intravenous; Injections, Spinal; Meningitis, Fungal; Oligodendroglioma; Polyesters | 2010 |